NCT00876005
Completed
Phase 4
Perioperative Supplemental Oxygen and the Risk of Surgical Site Infection
ConditionsSurgical Site Infection
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Surgical Site Infection
- Sponsor
- Santa Clara Valley Health & Hospital System
- Enrollment
- 1202
- Locations
- 1
- Primary Endpoint
- Surgical site infection
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
This is a study to see whether increasing the oxygen concentration during and after a cesarean section decreases the infection rate.
Detailed Description
This is a double-blinded prospective randomized,controlled trial to evaluate whether using a higher concentration of oxygen during and after surgery helps to decrease the wound infection rate in patients undergoing cesarean sections.
Investigators
Eligibility Criteria
Inclusion Criteria
- •mentally competent patients undergoing cesarean section under spinal or epidural anesthesia
Exclusion Criteria
- •fever/chorioamnionitis; GBS positive on antibiotics; immunocompromised / HIV patients; on antibiotics for any reason; general anesthesia; age less than 18 years custody patients stat cesarean section
Outcomes
Primary Outcomes
Surgical site infection
Time Frame: 2 weeks
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Supplemental Oxygen in Vascular SurgerySurgical Wound InfectionVascular SurgeryNCT00873704North Karelia Central Hospital274
Completed
Not Applicable
Supplemental Perioperative Oxygen to Reduce the Incidence of Post-Cesarean Endometritis and Wound InfectionWound Infection or Endometritis Post Cesarean SectionNCT00670020University of Washington143
Completed
Not Applicable
Oxygen Supplementation Study in Obstructive Sleep Apnea (OSA) PatientsObstructive Sleep ApneaNCT01552304University Health Network, Toronto196
Completed
Phase 3
Effect of Maternal and Neonatal OxygenationPeer Review, ResearchNCT01530971Mahidol University325
Completed
Not Applicable
Supplementary Oxygen in Surgical and Medical Wards Evaluated by 30-day MortalityOxygen ToxicityOxygen DeficiencyNCT03625700Hannibal Troensegaard11,196